Prenetics Global

PRE · NASDAQ

$18.63−$0.39 (−2.05%)TodayMarket closed ·
Prev close $19.02

About PRE

Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The firm's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The firm is also engaged in consumer health products by a new health and wellness brand IM8.

Employees
285
Headquarters
Hong Kong
Listed
Jul 6, 2021
Sector
Health Care
Industry
Health Care Providers & Services

Leadership

Prenetics Global executives
NameTitleSince
Sheng Wu Yeung——
Chi Hung Tzang——
Hoi Chun Lo——
Yung Ho Wong——
Samantha Kwok——
Jordan Lemerande——
Alan Thomas——
Joel Neoh——
Senthil Sundaram——
Andy Cheung——
Yin Pan Cheng—2023
Wing Kwan Chiu——
Kathryn Henry——
Darshan Shah——
David Vanderveen——

Revenue by product and region

Fiscal year ended Dec 31, 2023: $21.74M total revenue

By region

  • Taiwan$9.33M42.9%
  • Hong Kong$8.96M41.2%
  • United Kingdom$2.27M10.4%
  • Rest of the world$1.18M5.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.